XML 21 R5.htm IDEA: XBRL DOCUMENT v3.25.3
Consolidated Statements of Operations - USD ($)
 12 Months Ended
Jul. 31, 2025
Jul. 31, 2024
Jul. 31, 2023
Income Statement [Abstract]      
Net sales $ 499,528,000 $ 540,403,000 $ 549,994,000
Cost of sales 371,654,000 383,224,000 365,534,000
Gross profit 127,874,000 157,179,000 184,460,000
Expenses:      
Selling, general and administrative 143,487,000 123,198,000 120,003,000
Research and development 17,408,000 24,077,000 48,631,000
Amortization of intangibles 21,723,000 21,154,000 21,396,000
Impairment of long-lived assets, including goodwill 79,555,000 64,525,000 0
CEO transition costs 2,117,000 2,916,000 9,090,000
Loss on business divestiture 0 1,199,000 0
Proxy solicitation costs 2,682,000 0 0
Total operating expenses 266,972,000 237,069,000 199,120,000
Operating loss (139,098,000) (79,890,000) (14,660,000)
Other expenses (income):      
Interest expense 45,650,000 22,153,000 14,961,000
Interest (income) and other 155,000 678,000 1,226,000
Write-off of deferred financing costs and debt discounts 8,977,000 1,832,000 0
Change in fair value of warrants and derivatives (38,498,000) (4,273,000) 0
Loss before benefit from income taxes (155,382,000) (100,280,000) (30,847,000)
Income Tax Expense (Benefit) (80,000) (295,000) (3,948,000)
Net loss (155,302,000) (99,985,000) (26,899,000)
Gain (loss) on extinguishment of convertible preferred stock 51,179,000 (19,555,000) 0
Dividend on convertible preferred stock (100,128,000) (11,551,000) (7,007,000)
Convertible preferred stock issuance costs 0 (4,349,000) 0
Net loss attributable to common stockholders $ (204,251,000) $ (135,440,000) $ (33,906,000)
Net loss per share:      
Basic (in dollars per share) $ (6.95) $ (4.70) $ (1.21)
Diluted (in dollars per share) $ (6.95) $ (4.70) $ (1.21)
Weighted average number of common shares outstanding - basic (in shares) 29,405,000 28,799,000 28,002,000
Weighted average number of common and common equivalent shares outstanding - diluted (in shares) 29,405,000 28,799,000 28,002,000